Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_assertion type Assertion NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_head.
- NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_assertion description "[We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_provenance.
- NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_assertion evidence source_evidence_literature NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_provenance.
- NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_assertion SIO_000772 22057234 NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_provenance.
- NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_assertion wasDerivedFrom befree-20140225 NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_provenance.
- NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_assertion wasGeneratedBy ECO_0000203 NP351077.RAwK_v6gQ531XEtIoDSe46gJ4Pnkk7ci5jjZ-yvB54iVM130_provenance.